Proteinuria and the risk of developing end-stage renal disease

Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy

Barry M. Brenner, Mark E. Cooper, Dick de Zeeuw et al. · New England Journal of Medicine · 2001 · 7.5K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic Nephropathy

Edmund J. Lewis, Lawrence G. Hunsicker, Raymond P. Bain et al. · New England Journal of Medicine · 1993 · 5.4K citations

Medicine, Nephrology, Pharmacology +13

Effect of the Angiotensin-Converting–Enzyme Inhibitor Benazepril on the Progression of Chronic Renal Insufficiency

Giuseppe Maschio, Daniele Alberti, G. Janin et al. · New England Journal of Medicine · 1996 · 1.8K citations

Medicine, Pharmacology, Pharmacotherapy +14

The prognostic significance of proteinuria: The Framingham study

William B. Kannel, Meir J. Stampfer, William P. Castelli et al. · American Heart Journal · 1984 · 379 citations

Medicine, Nephrology, Clinical Epidemiology +10

Risk of developing end-stage renal disease in a cohort of mass screening

Kunitoshi Iseki, Chiho Iseki, Yoshiharu Ikemiya et al. · Kidney International · 1996 · 346 citations

Medicine, Internal Medicine, Nephrology +14